---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-001928"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2025-01-27T23:59:59+00:00"
generated_at: "2026-05-27T09:42:04.353923+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NRC Q4 revenue $36.9M, EPS $0.28; CTO Louvion resigns

## Summary
- Q4 revenue $36.9M vs $38.0M YoY; diluted EPS $0.28 vs $0.36.
- Net indebtedness $58.5M; total recurring contract value $133.2M at Dec 31, 2024.
- Returned $10.1M to shareholders: $7.3M in stock repurchases (393k shares) plus $0.12/share dividend.
- Chief Product Technology Officer Chrisophe Louvion resigned effective Jan 27, 2025.

## SEC filing metadata
- accession: 0001437749-25-001928
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2025-01-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774925001928/0001437749-25-001928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774925001928/nrc20250124_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-001928
- JSON: https://secwatch.observer/filing/0001437749-25-001928.json
- Plain text: https://secwatch.observer/filing/0001437749-25-001928.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.